Infections associated with use of the LifeSite Hemodialysis Access System.
We observed infection rates associated with the LifeSite Hemodialysis Access System, a novel dialysis device consisting of 2 subcutaneously implanted valves accessed by repeated use of fibrous tissue tracts, of 4.8 total infections and 8.1 first episodes per 1000 patient-days. These rates are higher than those observed elsewhere, which may be related to use of the device in a population of chronically ill patients, to the learning curve associated with use of the device, or to inherent qualities of the device.